# KCNA1

## Overview
The KCNA1 gene encodes the potassium voltage-gated channel subfamily A member 1, commonly referred to as Kv1.1, which is a crucial component of the voltage-gated potassium channel family. This protein functions as a transmembrane channel that plays a significant role in regulating electrical excitability in both neuronal and cardiac tissues. Kv1.1 channels are involved in controlling action potential dynamics, including initiation and propagation in neurons, and contribute to cardiac repolarization in atrial myocytes. The protein forms tetrameric structures, either as homotetramers or heterotetramers with other subunits, influencing its functional properties. Mutations in the KCNA1 gene are linked to various neurological disorders, such as episodic ataxia type 1 and epilepsy, highlighting its importance in maintaining normal physiological function (Paulhus2020Clinical; Glasscock2019Kv1.1).

## Structure
The KCNA1 gene encodes the Kv1.1 protein, a voltage-gated potassium channel α subunit. The primary structure of Kv1.1 consists of 495 amino acids, forming a sequence that includes six transmembrane (TM) regions labeled S1 through S6 (Paulhus2023Novel). The secondary structure is characterized by these transmembrane segments, which include alpha helices that span the cell membrane. The S1-S4 regions constitute the voltage-sensing domain, while the S5-S6 regions form the pore domain, crucial for ion conduction (Paulhus2023Novel).

The tertiary structure involves the folding of these segments into a three-dimensional conformation that allows the channel to function properly. The quaternary structure of Kv1.1 is a tetrameric assembly, where four α subunits come together to form a functional channel. These subunits can form either homo- or heterotetramers, often combining with other subunits like Kv1.2, Kv1.4, or Kv1.6 in vivo (Paulhus2023Novel).

The protein includes a K+ selectivity filter located in the extracellular linker between the S5 and S6 segments. The N-terminus is important for channel subunit assembly, while the C-terminus is involved in tetramerization and targeting the channel to the membrane (Paulhus2023Novel). Common post-translational modifications, such as phosphorylation, can affect the channel's activity.

## Function
The KCNA1 gene encodes the Kv1.1 voltage-gated potassium channel α-subunits, which play a crucial role in regulating neuronal and cardiac excitability. In neurons, Kv1.1 channels are involved in controlling action potential initiation, propagation, and repetitive firing properties. They form heterotetramers with other subunits such as Kv1.2, Kv1.4, and Kv1.6, which influence the channel's kinetics and gating properties. These channels mediate non-inactivating delayed rectifier currents, essential for maintaining neuronal excitability (Glasscock2019Kv1.1).

In the heart, Kv1.1 channels are expressed in atrial myocytes, where they contribute to cardiac repolarization and action potential waveform properties. Functional studies have shown that Kv1.1 channels contribute to outward potassium currents in human atrial myocytes, playing a significant role in maintaining normal cardiac electrical activity. The presence of Kv1.1 is crucial for preventing prolonged action potential durations and reducing susceptibility to atrial fibrillation (Glasscock2019Kv1.1).

Kv1.1 channels are active in the cell membrane, influencing nerve signal transmission and maintaining proper neuronal function. Their role in both the nervous and cardiac systems highlights their importance in the overall regulation of electrical excitability in the body (Glasscock2015Expression).

## Clinical Significance
Mutations in the KCNA1 gene, which encodes the Kv1.1 voltage-gated potassium channel, are associated with a range of neurological disorders. The most prominent condition linked to KCNA1 mutations is episodic ataxia type 1 (EA1), a disorder characterized by brief episodes of ataxia, myokymia, and other motor deficits. EA1 is often triggered by stressors such as exercise or emotional stress and is inherited in an autosomal dominant manner (Paulhus2020Clinical; Tomlinson2013Clinical; D’Adamo2020Kv1.1).

KCNA1 mutations are also implicated in epilepsy, including epileptic encephalopathies, which involve early onset seizures and cognitive impairments. Specific mutations, such as those in the PVP motif, are associated with both EA1 and epilepsy, highlighting the gene's role in neuronal excitability (Paulhus2020Clinical; D’Adamo2020Kv1.1). The gene's mutations can lead to a spectrum of conditions, including myokymia, paroxysmal dyskinesia, and hypomagnesemia, with some mutations affecting the Kv1.1 channel's surface expression and stability (Paulhus2020Clinical).

Alterations in KCNA1 expression or function can also contribute to sudden unexpected death in epilepsy (SUDEP) and neuro-cardiac dysfunction, further underscoring the gene's clinical significance (Paulhus2023Novel; D’Adamo2020Kv1.1).

## Interactions
The KCNA1 gene encodes the Kv1.1 voltage-gated potassium channel α-subunit, which is involved in forming functional channels through the assembly of four α-subunits. These can be either homo- or heterotetramers, often combining with other subunits such as Kv1.2, Kv1.4, or Kv1.6. These tetramers associate with β-subunits, which regulate the channel's structure, gating, assembly, and trafficking properties (Paulhus2023Novel). The Kv1.1 subunit interacts with other proteins, including synaptic proteins like PSD-95, which anchors it to the synaptic membrane, and forms complexes with other ion channels (Paulhus2023Novel).

Mutations in KCNA1 can affect these interactions. For instance, the P264LfsTer10 mutation results in a truncated protein that affects the voltage-sensing and pore domains, potentially leading to dominant-negative effects by associating with other Kv family subunits, such as Kv1.2 and Kv1.3. This interaction can trap channels in the endoplasmic reticulum, preventing them from reaching the cell surface and reducing their expression at the plasma membrane (Paulhus2023Novel). These interactions are crucial for the proper function of the Kv1.1 channels and their role in preventing neuronal hyperexcitability (Paulhus2023Novel).


## References


[1. (Tomlinson2013Clinical) Susan Elizabeth Tomlinson, Sanjeev Rajakulendran, Stella Veronica Tan, Tracey Dawn Graves, Doris-Eva Bamiou, Robyn W Labrum, David Burke, Carolyn M Sue, Paola Giunti, Stephanie Schorge, Dimitri M Kullmann, and Michael G Hanna. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. Journal of Neurology, Neurosurgery &amp; Psychiatry, 84(10):1107–1112, January 2013. URL: http://dx.doi.org/10.1136/jnnp-2012-304131, doi:10.1136/jnnp-2012-304131. This article has 40 citations.](https://doi.org/10.1136/jnnp-2012-304131)

[2. (Glasscock2019Kv1.1) Edward Glasscock. Kv1.1 channel subunits in the control of neurocardiac function. Channels, 13(1):299–307, January 2019. URL: http://dx.doi.org/10.1080/19336950.2019.1635864, doi:10.1080/19336950.2019.1635864. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/19336950.2019.1635864)

[3. (Glasscock2015Expression) Edward Glasscock, Niels Voigt, Mark D. McCauley, Qiang Sun, Na Li, David Y. Chiang, Xiao-Bo Zhou, Cristina E. Molina, Dierk Thomas, Constanze Schmidt, Darlene G. Skapura, Jeffrey L. Noebels, Dobromir Dobrev, and Xander H. T. Wehrens. Expression and function of kv1.1 potassium channels in human atria from patients with atrial fibrillation. Basic Research in Cardiology, July 2015. URL: http://dx.doi.org/10.1007/s00395-015-0505-6, doi:10.1007/s00395-015-0505-6. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00395-015-0505-6)

[4. (Paulhus2020Clinical) Kelsey Paulhus, Lauren Ammerman, and Edward Glasscock. Clinical spectrum of kcna1 mutations: new insights into episodic ataxia and epilepsy comorbidity. International Journal of Molecular Sciences, 21(8):2802, April 2020. URL: http://dx.doi.org/10.3390/ijms21082802, doi:10.3390/ijms21082802. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21082802)

[5. (Paulhus2023Novel) Kelsey Paulhus and Edward Glasscock. Novel genetic variants expand the functional, molecular, and pathological diversity of kcna1 channelopathy. International Journal of Molecular Sciences, 24(10):8826, May 2023. URL: http://dx.doi.org/10.3390/ijms24108826, doi:10.3390/ijms24108826. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24108826)

[6. (D’Adamo2020Kv1.1) Maria Cristina D’Adamo, Antonella Liantonio, Jean-Francois Rolland, Mauro Pessia, and Paola Imbrici. Kv1.1 channelopathies: pathophysiological mechanisms and therapeutic approaches. International Journal of Molecular Sciences, 21(8):2935, April 2020. URL: http://dx.doi.org/10.3390/ijms21082935, doi:10.3390/ijms21082935. This article has 64 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21082935)